Mr. Malo, our budget was increased by 80%. You are right in saying that it has almost doubled. However, one must remember that our workload practically doubled as well, and we were not responsible for that. This is a result of the fact that more patented drugs were introduced into the Canadian market and we had to conduct investigations to determine if prices were consistent with our guidelines. Therefore, we were not the ones responsible for creating the work. The pharmaceutical industry introduced more products into Canada.
In fact, we are now able to amend our guidelines. This project began more than three years ago, and we hope to complete it by June of this year. Things are taking longer because of the high number of consultations we have to carry out with people involved in the issue. All of this creates more work for us.